TABLE 2.
Variant | Protein (gene) | Genome nucleotide mutation | S or NS | AA mutation Rambaut et al., 2020 | Domain | Frequency* (%) | Effect |
B.1.1.7 | NSP2 (ORF1ab) | C913T | S | N/A | N/A | ||
NSP3 (ORF1ab) | C3267T | NS | T183I | 76.14 | N/A | ||
C5388A | NS | A890D | 76.24 | N/A | |||
C5986T | S | N/A | N/A | ||||
T6954C | NS | I1412T | 75.21 | N/A | |||
NSP6 (ORF1ab) | 11288-11296del | NS | ΔS106/ ΔG107/ΔF108 | 87.61 | N/A | ||
NSP12 (ORF1ab) | C14676T | S | N/A | N/A | |||
C15279T | S | N/A | N/A | ||||
NSP13 (ORF1ab) | C16176T | S | N/A | N/A | |||
S | 21765-21770del | NS | ΔH69/ΔV70 | NTD | 75.13 | Antibody escape Covid-19 Genomic UK Consortium, 2021 | |
21991-21993del | NS | ΔY144 | NTD | 76.91 | Decreases infectivity, Antibody escape Li Q. et al., 2020 | ||
A23063T | NS | N501Y | RBD | 80.16 | Increases affinity for hACE2 Wu et al., 2017 | ||
C23271A | NS | A570D | SD1 | 76.30 | |||
A23403G | NS | D614G | SD2 | 99.29 | Moderate increase in transmissibility Li Q. et al., 2020; Wu et al., 2017 | ||
C23709A | NS | P681H | SD2 | 79.18 | N/A | ||
C23709T | NS | T716I | 75.37 | N/A | |||
T24506G | NS | S982A | HR1 | 74.61 | N/A | ||
G24914C | NS | D1118H | 74.82 | N/A | |||
NS8 (ORF8) | C27972T | NS | Q27stop | 76.05 | Inactivation of NS8 Pereira, 2020 | ||
G28048T | NS | R52I | 76.00 | N/A | |||
A28111G | NS | Y73C | 76.07 | N/A | |||
M | T26801C | S | N/A | N/A | |||
N | G28280C | NS | D3L | 75.53 | N/A | ||
A28281T | NS | D3L | 75.53 | N/A | |||
T28282A | NS | D3L | 75.53 | N/A | |||
C28977T | NS | S235F | 76.34 | N/A |
*Mutation frequency as of April 30, 2021.